Accessibility Menu
Phibro Animal Health logo

Phibro Animal Health(NASDAQ) PAHC

Current Price$33.98
Market Cap$1.38BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2014)+153%
5 Year+59%
1 Year+17%
1 Month+9%
Phibro Animal Health last closing stock price
MetricPriceDate
Last closeUSD 34.042026-07-24
Phibro Animal Health stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.18%USD 33.312026-07-17
1 month+8.53%USD 31.362026-06-24
3 month-38.04%USD 54.932026-04-24
Year to date-8.3%USD 37.122025-12-31
1 year+17.06%USD 29.072025-07-24
3 year+149.86%USD 13.622023-07-25
5 year+58.89%USD 21.422021-07-23
Since inception+153.38%USD 13.432014-04-11

Phibro Animal Health Financials at a Glance

Market Cap

$1.38BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.50B

Net Income (TTM)

$95.23M

EPS (TTM)

$2.33

P/E Ratio

14.62

Dividend

$0.48

Beta (Volatility)

0.92 (Low)

Price

$33.98

Volume

137,276.81

Open

$34.21

Previous Close

$34.04

Daily Range

$33.68 - $34.75

52-Week Range

$25.58 - $60.08

Estimated Earnings Date

Aug 26, 2026

PAHC News

PiggyBank-BuyAlert-Purple.png

Is Beaten-Down Phibro Animal Health Stock a Buy Following an Insider Purchase of 10,000 Shares?

Cory RenauerJun 13, 2026
SellAlert-Green.png

Phibro's CEO transition puts this insider sale in context

Seena HassounaMay 23, 2026
SellAlert-Green.png

Phibro Animal Health's (PAHC) CEO Sold 21,120 Shares for $1.2 Million

Cory RenauerApr 28, 2026
SellAlert-Green.png

Phibro Animal Health's CEO Sold Over 14,000 Shares. Is the Stock a Buy or Sell?

Robert IzquierdoFeb 27, 2026
SellAlert-Blue.png

Phibro Animal Health President and CEO Sells 72k Shares After Strong Q2 2026 Performance

Adé HennisFeb 22, 2026
Foolcom-Featured.png

Phibro Animal Health Q4 Revenue Up 39%

Motley Fool Markets TeamAug 27, 2025
woman riding horse outside nature animal

Why Shares of Phibro Animal Health Are Dropping This Week

James HalleySep 7, 2023
puppyandkitten

3 Pet Med Stocks That Offer Growth and a Nice Dividend

James HalleyJun 2, 2020
Page 1

PAHC: Motley Fool Moneyball Superscore

67

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Phibro Animal Health

Phibro makes medicines and nutrients to keep farm animals healthy. These products help farmers grow stronger livestock like cattle and chickens. This ensures a steady supply of food for people worldwide.

What Phibro Sells

  • Animal Health: Medicated feed additives (MFAs), vaccines, and nutritional products for farm animals and dogs; earned $290 million in net sales in the quarter ended December 31, 2025.
  • Mineral Nutrition: Formulations of trace minerals like zinc and iron used to balance livestock diets; earned $69 million in net sales in the quarter ended December 31, 2025.
  • Performance Products: Specialty chemical ingredients used in industrial manufacturing and personal care; earned $15 million in net sales in the quarter ended December 31, 2025.

Recent Deals and Expansions

  • Completed the acquisition of the medicated feed additive portfolio from Zoetis on October 31, 2024.
  • Added six manufacturing facilities across the United States, China, and Italy through the Zoetis transaction.
  • Implemented the Phibro Forward program to drive revenue growth and reduce internal costs.
  • Secured a new credit agreement in July 2024 to fund acquisitions and refinance existing debt.

Global Production and Reach

The company makes its own raw ingredients for medicines at three plants in Israel and operates additional facilities in the US, Brazil, and Ireland. International sales are significant, with Israeli operations alone providing 16% of total net sales for the second half of 2025.

A Look at the Numbers

  • Net sales hit $373.9 million in the quarter ended December 31, 2025, up 20.9% year-over-year.
  • Net income reached $27.5 million in the quarter ended December 31, 2025, up 762.1% from the prior year.
  • Operating income grew to $50.3 million in the quarter ended December 31, 2025, up from $25.5 million in 2024.
  • Gross profit hit $132.7 million in the quarter ended December 31, 2025, up 30.2% year-over-year.

Bottom Line

Phibro has transformed from a general chemical supplier into a specialized provider of technical animal health products. Its focus on vaccines and the recent integration of a major medication portfolio support its long-term strategy in the livestock industry.

AI Generated • Apr 27, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

2,475

CEO

Jack C. Bendheim

Website

www.pahc.com

Headquarters

Teaneck, NJ 07666-6712, US

PAHC Financials

Key Financial Metrics (TTM)

Gross Margin

32.49%

Operating Margin

12.27%

Net Income Margin

6.35%

Return on Equity

29.49%

Return on Capital

10.55%

Return on Assets

6.59%

Earnings Yield

6.84%

Dividend Yield

1.41%

Payout Ratio

20.43%

Stock Overview

Market Cap

$1.38BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

40.56M

Volume

137.28K

Avg. Volume

364.25K

Financials (TTM)

Gross Profit

$487.32M

Operating Income

$184.00M

EBITDA

$225.31M

Operating Cash Flow

$66.13M

Capital Expenditure

-$53.36M

Free Cash Flow

$12.77M

Cash & ST Invst.

$77.45M

Total Debt

$787.44M

Phibro Animal Health Performance Analysis

Phibro Animal Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30USD 942,261,000N/A
20232023-06-30USD 977,889,0003.8%
20242024-06-30USD 1,017,679,0004.1%
20252025-06-30USD 1,296,215,00027.4%
Phibro Animal Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-06-308.9%
Q12025-09-30-3.9%
Q22025-12-312.8%
Q32026-03-312.6%
Phibro Animal Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30USD 1.21N/A
20232023-06-30USD 0.81-33.7%
20242024-06-30USD 0.06-92.6%
20252025-06-30USD 1.191890.8%
Phibro Animal Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-06-30-17.6%
Q12025-09-3054.8%
Q22025-12-313.1%
Q32026-03-31-11.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$383.54M

+10.3%

Gross Profit

$124.87M

+19.4%

Gross Margin

32.56%

N/A

Market Cap

$1.38BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$557.83K

N/A

Employees

2,475

N/A

Net Income

$24.02M

+15.1%

EBITDA

$55.64M

+8.3%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

$77.45M

+10.1%

Total Debt

$787.44M

+2.3%

Accounts Receivable

$221.55M

+12.2%

Inventory

$539.70M

+20.4%

Long Term Debt

$755.19M

+1.4%

Short Term Debt

$32.25M

+27.8%

Return on Assets

6.59%

N/A

Return on Invested Capital

15.82%

N/A

Free Cash Flow

$890.00K

-97.5%

Operating Cash Flow

$16.21M

-62.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MNKDMannKind Corporation
$4.13+6.17%
ALVOAlvotech
$3.06-3.77%
ANIPANI Pharmaceuticals, Inc.
$77.65-1.12%
AUPHAurinia Pharmaceuticals Inc.
$15.35+0.72%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
SOFISoFi Technologies
$16.46-0.01%
TAT&T
$24.13+0.05%

Questions About PAHC

What is the current price of Phibro Animal Health?

Phibro Animal Health is trading at $34.04 per share.

What is the 52-week range for Phibro Animal Health?

Over the past 52 weeks, Phibro Animal Health has traded between $25.58 and $60.08.

How much debt does Phibro Animal Health have?

As of the most recent reporting period, Phibro Animal Health reported total debt of $787.44M.

How much cash does Phibro Animal Health have on hand?

Phibro Animal Health reported $54.93M in cash and cash equivalents in its most recent financial results.

What is Phibro Animal Health’s dividend yield?

Phibro Animal Health currently has a dividend yield of 1.41%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services